H19 and postmenopausal osteoporosis: The data in our study indicated that estrogen inhibited miR-19b-3p, while elevated H19 expression in a dose-dependent manner, suggested a clear connection between estrogen and H19/miR-19b-3p, further confirm the biomarker potential of H19 and miR-19b-3p in postmenopausal osteoporosis.